Health

Results: 3613-3624 of 8227

3Z Pharmaceuticals Unveils Landmark Study Supporting Calcium Channel Blocker as a Groundbreaking ADHD Therapy

PR Newswire associated0

FIG makes a strategic investment in Elitepharm Laboratoires and brings AI to nutraceuticals

PR Newswire associated0

Stryker launches ProCeed hospital bed

PR Newswire associated0

Baltics leading pharmaceutical company Grindeks expands to new export markets worldwide

Business Wire logo

New ‘Super Test’ for Prostate Cancer Developed in the UK by EDX Medical

Business Wire logo

Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCE™, XBRYK™)

Business Wire logo

U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)

CE Mark Approval for RemeOs™ Trauma Screw Product Group, featuring four product lines with over 200 individual products, drives global expansion for Bioretec

President Halla Tomasdottir and Kerecis Founder and CEO Fertram Sigurjonsson (Photo: Business Wire)

Asa Gudmundsdottir Wright Award Presented as Plans for New Icelandic Academy of Science & Innovation Announced

Bioretec Ltd's Financial Statements 2024 published

Business Wire logo

Kao Corporation Discloses the "Board of Directors' Opinion on Shareholder Proposal and Kao’s Strategy to Enhance Corporate Value"

Business Wire logo

Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis